May 20, 2025 – Property intelligence provider Nearmap announced that it is acquiring itel, an independent provider of property claims solutions.

Private equity firm GTCR has reached an agreement to offload ITEL Laboratories (itel) to Nearmap, a portfolio company of ...

Nearmap, a leading property intelligence provider, today announced it is acquiring itel, an independent provider of critical ...

Thoma Bravo-backed Nearmap has agreed to buy insurance technology provider itel from private equity firm GTCR, the companies ...

The tech-focused buyout firm is purchasing Itel through its portfolio company Nearmap, according to a statement Tuesday.

ATG-022 is Antengene's CLDN18.2 antibody-drug conjugate; KEYTRUDA® (pembrolizumab) is MSD's anti-PD-1 therapy.

Nearmap, which is backed by Thoma Bravo, has agreed to acquire itel, a Jacksonville, Florida-based provider of property claims solutions. No financial terms were disclosed. The seller is GTCR. Based ...

GTCR, a leading private equity firm, announced that it has signed a definitive agreement to sell ITEL Laboratories, Inc. ("itel" or "the Company"), a leading provider of data and analytics to the P&C ...

Nearmap, a leading property intelligence provider, today announced it is acquiring itel, an independent provider of critical property claims solutions including building material pricing and ...